FIELD: biotechnology.
SUBSTANCE: strain A/17/Victoria/2011/89 (H3N2) propagates actively in developing chicken embryos at the optimum temperature of 32°C. It is characterised by temperature-sensitivity and cold-adaptiveness. The reassortant inherited genes encoding the surface antigens of virus of haemagglutinin (HA) and neuraminidase (NA), from the epidemic parental virus and other six genes encoding internal non-glycated proteins from attenuation donor. The strain is deposited in the State Collection of viruses FSBI "Research Institute of Virology n.a. DI Ivanovsky" under the number 2724.
EFFECT: invention can be used in practical healthcare for prevention of seasonal influenza morbidity among adults and children, using live influenza intranasal vaccine from the said strain.
1 dwg, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
STRAIN A/17/Texas/2012/30 (H3N2) OF INFLUEZA VIRUS FOR PRODUCING INTRANASAL LIVE INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2013 |
|
RU2563352C2 |
A/17/SINGAPORE/2016/3571 (H3N2) VACCINE INFLUENZA STRAIN FOR PRODUCING LIVE INFLUENZA INTRANAZAL VACCINE FOR ADULTS AND CHILDREN | 2018 |
|
RU2683500C1 |
STRAIN OF INFLUENZA VIRUS, GISK ¦ 147, USED FOR PREPARING INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2006 |
|
RU2319744C2 |
VACCINE STRAIN OF INFLUENZA VIRUS A/17/CALIFORNIA/04/6 (H3N2) AND ATTENUATION DONOR A/LENINGRAD/134/17/K7/57 (H2N2) FOR ITS PREPARING | 2006 |
|
RU2315101C2 |
REASSORTANT STRAIN OF INFLUENZA VIRUS A/17/VICTORIA/2019/276 (H1N1) PDM09 FOR THE PRODUCTION OF LIVE INTRANASAL INFLUENZA VACCINE FOR ADULTS AND CHILDREN | 2022 |
|
RU2783878C1 |
INFLUENZA VIRUS STRAIN FOR PRODUCING LIVE AND INACTIVATED INFLUENZA VACCINE | 2011 |
|
RU2464309C1 |
INFLUENZA VIRUS A/17/WYOMING/03/8 (H3N2) STRAIN FOR PRODUCTION OF LIVING INFLUENZA INTRANASAL VACCINE FOR INFANTS AND ADULTS | 2004 |
|
RU2285723C2 |
STRAIN OF INFLUENZA VIRUS A/17/INDIANA/11/72 (H3N2v) FOR PRODUCTION OF LIQUID INFLUENZA INTRANASAL VACCINE FOR ADULTS AND FOR CHILDREN | 2013 |
|
RU2545706C1 |
VACCINE INFLUENZA VIRUS STRAIN A/17/HONGKONG/2014/8296 (H3N2) FOR PREPARING LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2016 |
|
RU2606019C1 |
REASSORTANT VACCINE STRAIN OF INFLUENZA VIRUS A/17/TASMANIA/2020/151 (H3N2) FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND FOR CHILDREN | 2023 |
|
RU2825672C1 |
Authors
Dates
2014-11-10—Published
2012-07-17—Filed